Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer-Reference-Cited by-同舟云学术

Lithographically defined encoded magnetic heterostructures for the targeted screening of kidney cancer

Published:2024 Issue:1 Volume:6 Page:276-286
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Leulmi Pichot Selma¹^ORCID,Vemulkar Tarun²,Verheyen Jeroen²,Wallis Lauren³,Jones James O.⁴,Stewart Andrew P.⁵^ORCID,Welsh Sarah J.³,Stewart Grant D.³^ORCID,Cowburn Russell P.¹

Affiliation:

1. The Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, CB3 0HE, UK

2. Semarion Limited, CB3 0HE, UK

3. Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK

4. Department of Oncology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK

5. Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK

Abstract

Renal cell carcinoma (RCC) is the 7th commonest cancer in the UK and the most lethal urological malignancy; 50% of all RCC patients will die from the condition.

Funder

Rosetrees Trust

Mark Foundation For Cancer Research

Cancer Research UK

NIHR Cambridge Biomedical Research Centre

Academy of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NA/D3NA00701D

Reference28 articles.

1. The multispeciality approach to the management of localised kidney cancer

2. Cancer incidence and mortality projections in the UK until 2035

3. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

4. Current evidence on screening for renal cancer